The phase 2 Cadence trial met its primary endpoint, showing that Winrevair improved the ability of blood to transition through the lungs to the heart in patients with combined post- and precapillary ...

Following the FDA’s September announcement of a crackdown on direct-to | Monday, the FDA’s Office of Prescription Drug ...

Now, more than half a year later, the expansion plan for one of the company’s new facilities—a former magazine plant in ...

Having found swift success with its Jazz Pharmaceuticals and BeOne Medicines-licensed cancer med Ziihera, Zymeworks has ...

Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by ...